FDA Deems GM Apples, Potatoes Safe

Genetically modified, non-browning apples and bruise-resistant potatoes are safe, the US Food and Drug Administration says.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

An Arctic Granny apple (right) resists browning after eight hours exposed to air, as compared with an unmodified variety (left).OKANAGAN SPECIALTY FRUITSThe US Food and Drug Administration (FDA) has deemed genetically modified (GM), non-browning “Arctic” apples—approved last month by the Department of Agriculture—and bruise-resistant “Innate” potatoes “as safe and nutritious as their conventional counterparts,” according to The New York Times.

Okanagan Specialty Fruits, the British Columbia-based firm that produces the GM apples, and J.R. Simplot of Idaho, which grows the GM potatoes, both consulted with the FDA to assess the safety and nutrition of their foods.

“The consultation process includes a review of information provided by a company about the nature of the molecular changes and the nutritional composition of the food compared to traditionally bred varieties,” Dennis Keefe, director of the agency’s Office of Food Additive Safety, said in a statement. “This case-by-case safety evaluation ensures that food safety issues are resolved prior to commercial distribution.”

The agency also urged both companies to consult with the FDA about potential labeling requirements. Simplot told the Associated Press (AP) that it plans to deliver Innate potato ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies